蕭 鎮源

Medicine & Life Sciences

1. ferulic acid 100%
2. Enzyme Replacement Therapy 91%
3. Hydrogels 75%
4. Cardiomyopathies 68%
5. Intra-Abdominal Hypertension 57%
6. Wharton Jelly 53%
7. globotriaosyl lysosphingolipid 53%
8. Thoracostomy 49%
9. Daptomycin 48%
10. Fosfomycin 48%
11. Hemothorax 47%
12. Vinorelbine 46%
13. Length of Stay 46%
14. Fractals 46%
15. Acute Necrotizing Pancreatitis 46%
16. Chitosan 45%
17. Aortic Rupture 44%
18. Injections 44%
19. Oxidative Stress 43%
20. Experimental Diabetes Mellitus 41%
21. Pancreaticoduodenectomy 41%
22. Sternotomy 41%
23. Intensive Care Units 40%
24. Calcitonin 40%
25. Ovariectomy 39%
26. Peripheral Arterial Disease 38%
27. Abdominal Aortic Aneurysm 38%
28. Peritoneal Dialysis 38%
29. Atlases 37%
30. Endocarditis 36%
31. Osteoclasts 36%
32. Geriatrics 33%
33. Heart Ventricles 32%
34. Cardiac Myocytes 32%
35. Aspirin 32%
36. Inflammation 32%
37. Thoracic Surgery 31%
38. Mesenchymal Stem Cells 31%
39. Osteogenesis 30%
40. Staphylococcus aureus 30%
41. Thorax 29%
42. Therapeutic Uses 28%
43. Catheters 27%
44. Mortality 26%
45. Biomarkers 26%
46. Hematuria 24%
47. Light 24%
48. Insulin 23%
49. Pressure 22%
50. Serum 22%